Skip to main content

Q BioMed Inc. — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)
$284.4K
Net Income/Loss (FY2022)
-$2.1M
Total Assets (FY2022)
$3.5M
Total Equity (FY2022)
-$4.6M
Cash Flows from Operating Activities (FY2022)
$1.9M

Source: Q BioMed Inc. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Discover Hub-Equity